TIAA CREF Investment Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $6.42M | Sell |
183,119
-1,968
| -1% | -$69K | ﹤0.01% | 1288 |
|
|
2018
Q4 | $6.15M | Sell |
185,087
-1,811
| -1% | -$60.2K | ﹤0.01% | 1246 |
|
|
2018
Q3 | $9.41M | Sell |
186,898
-9,556
| -5% | -$481K | 0.01% | 1137 |
|
|
2018
Q2 | $11.8M | Buy |
196,454
+1,060
| +0.5% | +$63.4K | 0.01% | 1055 |
|
|
2018
Q1 | $8.95M | Buy |
195,394
+76,562
| +64% | +$3.51M | 0.01% | 1190 |
|
|
2017
Q4 | $4.74M | Sell |
118,832
-54,668
| -32% | -$2.18M | ﹤0.01% | 1637 |
|
|
2017
Q3 | $6.94M | Sell |
173,500
-56,005
| -24% | -$2.24M | ﹤0.01% | 1412 |
|
|
2017
Q2 | $9.89M | Buy |
229,505
+4,571
| +2% | +$197K | 0.01% | 1143 |
|
|
2017
Q1 | $7.04M | Sell |
224,934
-7,720
| -3% | -$242K | 0.01% | 1361 |
|
|
2016
Q4 | $5.88M | Sell |
232,654
-9,357
| -4% | -$236K | ﹤0.01% | 1493 |
|
|
2016
Q3 | $5.99K | Sell |
242,011
-9,339
| -4% | -$231 | ﹤0.01% | 1477 |
|
|
2016
Q2 | $5.12M | Buy |
251,350
+60,391
| +32% | +$1.23M | ﹤0.01% | 1524 |
|
|
2016
Q1 | $2.91M | Buy |
190,959
+51,580
| +37% | +$787K | ﹤0.01% | 1868 |
|
|
2015
Q4 | $1.87M | Sell |
139,379
-6,856
| -5% | -$92.1K | ﹤0.01% | 2196 |
|
|
2015
Q3 | $2.05M | Buy |
146,235
+20,845
| +17% | +$293K | ﹤0.01% | 2122 |
|
|
2015
Q2 | $2.13M | Buy |
125,390
+23,701
| +23% | +$402K | ﹤0.01% | 2263 |
|
|
2015
Q1 | $1.23M | Hold |
101,689
| – | – | ﹤0.01% | 2499 |
|
|
2014
Q4 | $844K | Sell |
101,689
-14,972
| -13% | -$124K | ﹤0.01% | 2748 |
|
|
2014
Q3 | $1.01M | Sell |
116,661
-14,800
| -11% | -$129K | ﹤0.01% | 2615 |
|
|
2014
Q2 | $1.44M | Buy |
131,461
+48,247
| +58% | +$528K | ﹤0.01% | 2496 |
|
|
2014
Q1 | $744K | Buy |
83,214
+23,989
| +41% | +$214K | ﹤0.01% | 2800 |
|
|
2013
Q4 | $447K | Sell |
59,225
-7,140
| -11% | -$53.9K | ﹤0.01% | 2992 |
|
|
2013
Q3 | $486K | Buy |
66,365
+10,829
| +19% | +$79.3K | ﹤0.01% | 2946 |
|
|
2013
Q2 | $357K | Buy |
+55,536
| New | +$357K | ﹤0.01% | 3007 |
|